REFERENCES



Choose an author or browse all
Choose the species or browse all
Choose a criteria for sorting
 Reverse sorting
Search for a protein
Search for a single PMID
Download references as CSV

Select O-GlcNAc references filter

Click to expand (1 result)

*Color correspond to species


Shan S, Chen W, Wu W, Zhang W, Liu J, Liao W, Wen Y, Zhao C. Green Alga Enteromorpha prolifera Oligosaccharide Exerts Antiaging Effects through Targeted Modulation of Protein O-GlcNAcylation. Journal of agricultural and food chemistry 2026 41549750
Abstract:
Aging and diabetes are intricately linked, with metabolic dysregulation playing a pivotal role in the pathophysiology of both conditions. This study investigates the therapeutic potential of Enteromorpha prolifera oligosaccharide (EPO) in mitigating aging-related metabolic decline through modulation of O-GlcNAcylation. The results demonstrate that EPO treatment significantly reduced O-GlcNAc levels, thereby attenuating ROS accumulation and alleviating cell cycle arrest to counteract aging-associated metabolic decline. Specifically, shOGA increased ROS by 77.0% and induced G2/M arrest (12.2%). These alterations were mimicked by TMG but reversed by EPO, identifying OGA as the primary driver of ROS generation and cell cycle regulation. shHCF1 decreased ROS (48.8% to 28.3%), G0/G1 (59.7%), and S phase (6.6%) but increased G2/M to 30.9%, suggesting ROS attenuation alongside G2/M arrest. Overall, this research highlights the role of EPO in regulating key cellular processes, providing new insights for the development of antiaging therapies.
Page 1 of 1